Cluster 3 contained the majority of the SDHB-RCC tumors and had a mixture of probes with high and low β-values, suggesting a methylated phenotype that is less extensive and more variable than in the HLRCC tumors (Fig 1A). Here, SDHB is linked to hereditary leiomyomatosis and renal cell cancer.